Literature DB >> 8082041

Ischemic damage visualized in flat mounts of rat retina after photochemically induced thrombosis.

R Schmidt-Kastner1, U T Eysel.   

Abstract

The method of photochemically induced thrombosis was used to produce severe ischemia in the rat retina. Flat mounts of the retina were prepared at 3 h, and 1, 2, 3, 4, 6, 7, and 22 days after lesioning and Nissl-stained, which facilitated the study of the topography of the ischemic lesions. The regional variability of ischemic damage and the cytological features of ischemic cell death in the ganglion cell layer were evaluated. Neuropathological analysis showed ischemic cell damage of ganglion cells at 3 h, an infarction-type lesion at 1 to 7 days, and scar formation at 3 weeks. As an additional parameter of ischemic ganglion cell death, the degeneration of retinal axons was visualized in the contralateral dorsal lateral geniculate nucleus by Fink-Heimer silver impregnation and by immunohistochemical staining for glial fibrillary acidic protein (GFAP) in reactive astrocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082041     DOI: 10.1016/0361-9230(94)90022-1

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  2 in total

1.  Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion.

Authors:  Marcelo Ganzella; Enderson Dias Alves de Oliveira; Daniel Diniz Comassetto; Fernanda Cechetti; Victor Hermes Cereser; Júlia Dubois Moreira; Gisele Hansel; Roberto Farina Almeida; Denise Barbosa Ramos; Yanier Nuñes Figueredo; Debora Guerini Souza; Jean Pierre Oses; Paulo Valdeci Worm; Matilde Achaval; Carlos Alexandre Netto; Diogo Onofre Souza
Journal:  Neurol Sci       Date:  2011-12-14       Impact factor: 3.307

2.  Preclinical models to investigate retinal ischemia: advances and drawbacks.

Authors:  Gillipsie Minhas; Ryuichi Morishita; Akshay Anand
Journal:  Front Neurol       Date:  2012-05-11       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.